This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maurin, M.
Right arrow Articles by Dumler, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maurin, M.
Right arrow Articles by Dumler, J. S.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, January 2003, p. 413-415, Vol. 47, No. 1
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.1.413-415.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Antibiotic Susceptibilities of Anaplasma (Ehrlichia) phagocytophilum Strains from Various Geographic Areas in the United States

Max Maurin,1,2 Johan S. Bakken,3 and J. Stephen Dumler2*

Unité des Rickettsies, Université de la Méditerranée, Faculté de Médecine, Marseille, France,1 Section of Infectious Diseases, SMDC Health System, Duluth, Minnesota,3 Division of Medical Microbiology, Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland2

Received 12 December 2001/ Returned for modification 19 June 2002/ Accepted 3 October 2002

We tested the antibiotic susceptibilities of eight strains of Anaplasma phagocytophilum (the agent of human granulocytic ehrlichiosis) collected in various geographic areas of the United States, including Minnesota, Wisconsin, California, and New York. The results are homogeneous and show that doxycycline, rifampin, and levofloxacin are the most active antibiotics against these strains in vitro.

* Corresponding author. Mailing address: Division of Medical Microbiology, Department of Pathology, The Johns Hopkins Medical Institutions, Meyer B1-193, 600 North Wolfe St., Baltimore, MD 21287. Phone: (410) 955-5077. Fax: (410) 614-8087. E-mail: sdumler{at}jhmi.edu.

Antimicrobial Agents and Chemotherapy, January 2003, p. 413-415, Vol. 47, No. 1
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.1.413-415.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Patnaik, M. M. (2009). Inclusion Bodies in Tick-Borne Diseases Diagnosed in Patients from Northern Wisconsin. Clin Med Res 7: 45-47 [Full Text]  
  • Zeidner, N. S., Massung, R. F., Dolan, M. C., Dadey, E., Gabitzsch, E., Dietrich, G., Levin, M. L. (2008). A sustained-release formulation of doxycycline hyclate (Atridox) prevents simultaneous infection of Anaplasma phagocytophilum and Borrelia burgdorferi transmitted by tick bite. J Med Microbiol 57: 463-468 [Abstract] [Full Text]  
  • Swanson, S. J., Neitzel, D., Reed, K. D., Belongia, E. A. (2006). Coinfections Acquired from Ixodes Ticks. Clin. Microbiol. Rev. 19: 708-727 [Abstract] [Full Text]  
  • Branger, S., Rolain, J. M., Raoult, D. (2004). Evaluation of Antibiotic Susceptibilities of Ehrlichia canis, Ehrlichia chaffeensis, and Anaplasma phagocytophilum by Real-Time PCR. Antimicrob. Agents Chemother. 48: 4822-4828 [Abstract] [Full Text]  
  • Krause, P. J., Corrow, C. L., Bakken, J. S. (2003). Successful Treatment of Human Granulocytic Ehrlichiosis in Children Using Rifampin. Pediatrics 112: e252-253 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»